BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12185598)

  • 1. Rare mutations of the DMBT1 gene in human astrocytic gliomas.
    Mueller W; Mollenhauer J; Stockhammer F; Poustka A; von Deimling A
    Oncogene; 2002 Aug; 21(38):5956-9. PubMed ID: 12185598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.
    Sasaki H; Betensky RA; Cairncross JG; Louis DN
    Cancer Res; 2002 Mar; 62(6):1790-6. PubMed ID: 11912156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
    Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability.
    Mollenhauer J; Holmskov U; Wiemann S; Krebs I; Herbertz S; Madsen J; Kioschis P; Coy JF; Poustka A
    Oncogene; 1999 Nov; 18(46):6233-40. PubMed ID: 10597221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.
    Pang JC; Dong Z; Zhang R; Liu Y; Zhou LF; Chan BW; Poon WS; Ng HK
    Int J Cancer; 2003 May; 105(1):76-81. PubMed ID: 12672033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome.
    Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer.
    Mollenhauer J; Müller H; Kollender G; Lyer S; Diedrichs L; Helmke B; Holmskov U; Ligtenberg T; Herbertz S; Krebs I; Madsen J; Bikker F; Schmitt L; Wiemann S; Scheurlen W; Otto HF; von Deimling A; Poustka A
    Genes Chromosomes Cancer; 2002 Nov; 35(3):242-55. PubMed ID: 12353266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of somatic TP53 splice site mutations in diffuse astrocytomas.
    Uno M; Oba-Shinjo SM; de Aguiar PH; Leite CC; Rosemberg S; Miura FK; Junior RM; Scaff M; Nagahashi Marie SK
    Cancer Lett; 2005 Jun; 224(2):321-7. PubMed ID: 15914282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis.
    Mollenhauer J; Helmke B; Medina D; Bergmann G; Gassler N; Müller H; Lyer S; Diedrichs L; Renner M; Wittig R; Blaich S; Hamann U; Madsen J; Holmskov U; Bikker F; Ligtenberg A; Carlén A; Olsson J; Otto HF; O'Malley B; Poustka A
    Genes Chromosomes Cancer; 2004 Mar; 39(3):185-94. PubMed ID: 14732920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.
    Mollenhauer J; Herbertz S; Holmskov U; Tolnay M; Krebs I; Merlo A; Schrøder HD; Maier D; Breitling F; Wiemann S; Gröne HJ; Poustka A
    Cancer Res; 2000 Mar; 60(6):1704-10. PubMed ID: 10749143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.
    Mollenhauer J; Wiemann S; Scheurlen W; Korn B; Hayashi Y; Wilgenbus KK; von Deimling A; Poustka A
    Nat Genet; 1997 Sep; 17(1):32-9. PubMed ID: 9288095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
    Arjona D; Bello MJ; Alonso ME; Aminoso C; Isla A; De Campos JM; Sarasa JL; Gutierrez M; Villalobo A; Rey JA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):384-94. PubMed ID: 16008822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mitochondrial mutations in pilocytic astrocytoma.
    Lueth M; Wronski L; Giese A; Kirschner-Schwabe R; Pietsch T; von Deimling A; Henze G; Kurtz A; Driever PH
    Cancer Genet Cytogenet; 2009 Jul; 192(1):30-5. PubMed ID: 19480934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IV.
    Wessels PH; Twijnstra A; Kubat B; Ummelen MI; Claessen SM; Sciot R; Merlo A; Ramaekers FC; Speel EJ; Hopman AH
    Genes Chromosomes Cancer; 2004 Jan; 39(1):22-8. PubMed ID: 14603438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors.
    Franco-Hernandez C; Martinez-Glez V; Arjona D; de Campos JM; Isla A; Gutierrez M; Vaquero J; Rey JA
    Cancer Genet Cytogenet; 2007 Feb; 173(1):63-7. PubMed ID: 17284372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutations in glioblastoma multiforme.
    Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
    Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.